ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2020
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- [Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis].Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2022Pooled it
- Relationship Between Androgen Deprivation Therapy for Prostate Cancer and Risk of SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.Journal of Korean medical science · 2022Pooled it
- Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19: The HITCH Randomized Clinical Trial.JAMA network open · 2022Trial
- Article
- Review
- The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer.JNCI cancer spectrum · 2022Article
- Influence of androgen deprivation therapy on the severity of COVID-19 in prostate cancer patients.The Prostate · 2021Article
- The clinical impact of androgen deprivation therapy on SARS-CoV-2 infection rates and disease severity.Turkish journal of urology · 2021Article
- Severe acute respiratory syndrome coronavirus 2 infection in patients with prostate cancer: A critical review.Critical reviews in oncology/hematology · 2021Review
- Extraordinary claims without extraordinary evidence: controversy on anti-androgen therapy for COVID-19.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?Endocrinology · 2021Article
- Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.Journal of medical virology · 2021Review
- Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.Dermatologic therapy · 2021Review
- Cardiovascular Toxicities of Androgen Deprivation Therapy.Current treatment options in oncology · 2021Review
- Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.Nature communications · 2021Article
- Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.PloS one · 2021Article
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection.Therapeutic advances in endocrinology and metabolism · 2021Review
- Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?Biomolecules · 2020Review
- The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.Future oncology (London, England) · 2020Article
- Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer.Cancers · 2020Article
Corrections and comments
- Comment on
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.